220 related articles for article (PubMed ID: 30328647)
41. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
42. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
van de Merwe JP; van den Beemd MW; Hooijkaas H
Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
[TBL] [Abstract][Full Text] [Related]
43. Targeting primary Sjögren's syndrome.
Odani T; Chiorini JA
Mod Rheumatol; 2019 Jan; 29(1):70-86. PubMed ID: 30424703
[TBL] [Abstract][Full Text] [Related]
44. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
45. Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
Bodewes ILA; van der Spek PJ; Leon LG; Wijkhuijs AJM; van Helden-Meeuwsen CG; Tas L; Schreurs MWJ; van Daele PLA; Katsikis PD; Versnel MA
Front Immunol; 2019; 10():312. PubMed ID: 30863411
[No Abstract] [Full Text] [Related]
46. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
Luo D; Chen Y; Zhou N; Li T; Wang H
Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
[TBL] [Abstract][Full Text] [Related]
47. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
[TBL] [Abstract][Full Text] [Related]
48. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
49. Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial.
Posada J; Valadkhan S; Burge D; Davies K; Tarn J; Casement J; Jobling K; Gallagher P; Wilson D; Barone F; Fisher BA; Ng WF
Arthritis Rheumatol; 2021 Jan; 73(1):143-150. PubMed ID: 32798283
[TBL] [Abstract][Full Text] [Related]
50. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
[TBL] [Abstract][Full Text] [Related]
51. Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.
Alunno A; Nocentini G; Bistoni O; Petrillo MG; Bartoloni Bocci E; Ronchetti S; Lo Vaglio E; Riccardi C; Gerli R
Reumatismo; 2012 Dec; 64(5):293-8. PubMed ID: 23256104
[TBL] [Abstract][Full Text] [Related]
52. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
53. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
54. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.
Ciccia F; Guggino G; Rizzo A; Ferrante A; Raimondo S; Giardina A; Dieli F; Campisi G; Alessandro R; Triolo G
Ann Rheum Dis; 2012 Feb; 71(2):295-301. PubMed ID: 21979002
[TBL] [Abstract][Full Text] [Related]
55. Biological therapies in primary Sjögren's syndrome.
Ng WF; Bowman SJ
Expert Opin Biol Ther; 2011 Jul; 11(7):921-36. PubMed ID: 21457124
[TBL] [Abstract][Full Text] [Related]
56. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome.
Hartkamp A; Geenen R; Bijl M; Kruize AA; Godaert GL; Derksen RH
Ann Rheum Dis; 2004 Oct; 63(10):1335-7. PubMed ID: 15361396
[TBL] [Abstract][Full Text] [Related]
57. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
58. The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjögren's syndrome and its correlation with anxiety and depression.
Xie B; Chen Y; Zhang S; Wu X; Zhang Z; Peng Y; Huang X
Clin Exp Rheumatol; 2014; 32(3):354-60. PubMed ID: 24480517
[TBL] [Abstract][Full Text] [Related]
59. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
60. A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.
James K; Al-Ali S; Tarn J; Cockell SJ; Gillespie CS; Hindmarsh V; Locke J; Mitchell S; Lendrem D; Bowman S; Price E; Pease CT; Emery P; Lanyon P; Hunter JA; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; ; Wipat A; Newton J; Jones DE; Isaacs J; Hallinan J; Ng WF
PLoS One; 2015; 10(12):e0143970. PubMed ID: 26694930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
